Evaluation of survivin mRNA antigen lipid nanoparticles and CTLA 4 inhibitor combination for effective oral carcinoma immunotherapy

dc.contributor.authorK, Vandana
dc.date.accessioned2026-07-17T10:37:58Z
dc.date.issued2025
dc.descriptionUnder the Supervision of Prof. Venkata Vamsi Krishna Venuganti
dc.identifier.urihttps://shodhganga.inflibnet.ac.in/handle/10603/700511
dc.language.isoen
dc.publisherBITS PILANI, Hyderabad campus
dc.subjectPHARMACY
dc.subjectSurvivin mRNA antigen
dc.subjectCTLA 4 inhibitor
dc.subjectOral carcinoma
dc.titleEvaluation of survivin mRNA antigen lipid nanoparticles and CTLA 4 inhibitor combination for effective oral carcinoma immunotherapy
dc.typeThesis

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: